In cancer, the regulation of TXNIP may be one of the mechanisms underlying proliferation and cancer progression, and TXNIP has a relatively small effect on tumor survival compared to the overall pathway-mediated inhibition of oncogenic drivers. The gene discussed is TXNIP; the disease is neoplasm.